CervoMed(CRVO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CRVO CervoMed

Market Closed 07-02 16:00:00 EDT

3.55

-0.14

-3.79%

盘后3.55

+0.000.00%

19:58 EDT

High3.69	Low3.45	Vol310.12K
Open3.64	D1 Closing3.69	Amplitude6.50%
Mkt Cap48.02M	Tradable Cap17.52M	Total Shares13.53M
T/O1.09M	T/O Rate6.28%	Tradable Shares4.93M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CRVO","market":"US","secType":"STK","nameCN":"CervoMed","latestPrice":3.55,"timestamp":1783022400000,"preClose":3.69,"halted":0,"volume":310116,"hourTrading":{"tag":"盘后","latestPrice":3.55,"preClose":3.55,"latestTime":"19:58 EDT","volume":13772,"amount":48726.5194,"timestamp":1783036726727,"change":0,"changeRate":0,"amplitude":0.036592},"delay":0,"changeRate":-0.03794037940379407,"floatShares":4934300,"shares":13526200,"eps":-3.273729,"marketStatus":"Market Closed","change":-0.14,"latestTime":"07-02 16:00:00 EDT","open":3.64,"high":3.69,"low":3.45,"amount":1093251.1284983999,"amplitude":0.065041,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.273729,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1783324800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":3.69,"preHourTrading":{"tag":"盘前","latestPrice":3.64,"preClose":3.69,"latestTime":"09:29 EDT","volume":7395,"amount":26509.073913,"timestamp":1782998999999,"change":-0.05,"changeRate":-0.01355,"amplitude":0.037995},"postHourTrading":{"tag":"盘后","latestPrice":3.55,"preClose":3.55,"latestTime":"19:58 EDT","volume":13772,"amount":48726.5194,"timestamp":1783036726727,"change":0,"changeRate":0,"amplitude":0.036592},"volumeRatio":0.42128537433760194},"requestUrl":"/m/hq/s/CRVO/wiki","defaultTab":"wiki","newsList":[{"id":"2646039738","title":"H.C. Wainwright Keeps Their Buy Rating on CervoMed (CRVO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2646039738","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646039738?lang=en_us&edition=fundamental","pubTime":"2026-06-25 20:56","pubTimestamp":1782392189,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on CervoMed today and set a price target of $25.00. Selvaraju covers the Healthcare s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-cervomed-crvo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-cervomed-crvo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645288008","title":"CervoMed Closes $10 Million Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2645288008","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645288008?lang=en_us&edition=fundamental","pubTime":"2026-06-23 05:38","pubTimestamp":1782164293,"startTime":"0","endTime":"0","summary":"CervoMed (CRVO) closed a previously announced registered direct offering of 2.5 million shares at $4 per share for gross proceeds of $10 million, the company said late Monday.The company plans to use the proceeds for working capital and general corporate purposes.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645070199","title":"CervoMed Raises $10 Million in Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2645070199","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645070199?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:30","pubTimestamp":1782160215,"startTime":"0","endTime":"0","summary":"CervoMed ( ($CRVO) ) just unveiled an update. On June 22, 2026, CervoMed Inc. closed a registered direct offering of 2,500,000 shares of common sto...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cervomed-raises-10-million-in-direct-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cervomed-raises-10-million-in-direct-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645207797","title":"CervoMed Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2645207797","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645207797?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:05","pubTimestamp":1782158700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nTUAPKLC2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645034260","title":"CervoMed Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2645034260","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645034260?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:05","pubTimestamp":1782158700,"startTime":"0","endTime":"0","summary":"BOSTON, June  22, 2026  (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/22/3315604/0/en/CervoMed-Announces-Closing-of-10-Million-Registered-Direct-Offering-of-Common-Stock-Priced-At-The-Market-Under-Nasdaq-Rules.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DLB","BK4097","LU0345774391.USD","LU0348723411.USD","BK4139","LU0205194284.USD","LU0240878834.USD","LU0205193047.USD","LU0345774631.USD","LU0240877869.USD","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645529025","title":"CervoMed prices USD 10 million registered direct stock offering at USD 4 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2645529025","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645529025?lang=en_us&edition=fundamental","pubTime":"2026-06-22 18:02","pubTimestamp":1782122571,"startTime":"0","endTime":"0","summary":"CervoMed launched a USD 10 million registered direct offering of 2,500,000 common shares priced at USD 4 per share.Closing expected on or about June 22, 2026, subject to customary conditions.Net proceeds earmarked for working capital, general corporate purposes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cervomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL2zSmht:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644038699","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2644038699","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644038699?lang=en_us&edition=fundamental","pubTime":"2026-06-19 01:32","pubTimestamp":1781803938,"startTime":"0","endTime":"0","summary":"CervoMed  received a notice of allowance from the US Patent and Trademark Office for a patent application related to the use of its drug candidate, neflamapimod, to treat dementia with Lewy bodies, the company said Thursday.Shares jumped more than 10% following an increase in intraday trading volume to over 99.9 million from a daily average of about 3.5 million.Quantum X Labs  launched a quantum computing program that combines its proprietary algorithms for clinical trial data analysis with its Quantum Error Correction, or QECC, Decoder technology to maximize computational accuracy and reliability, the company said Thursday.Shares advanced 13% as intraday trading volume jumped to over 300,000 from a daily average of about 70,000.Smith & Wesson Brands  overnight reported a year-over-year jump in fiscal Q4 non-GAAP earnings and net sales.Shares surged 18% amid a jump in intraday trading volume to over 2.9 million from a daily average of roughly 584,000.Price: 4.21, Change: +0.40, Percent","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRVO","BK4190","SWBI","BK4009","QXL","BK4532","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644804700","title":"CervoMed Reports $10 Million Direct Offering of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2644804700","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644804700?lang=en_us&edition=fundamental","pubTime":"2026-06-19 00:52","pubTimestamp":1781801563,"startTime":"0","endTime":"0","summary":"CervoMed  said Thursday it has struck a deal to sell 2.5 million shares at $4.00 per share in a registered direct offering, with H.C. Wainwright as the placement agent.The clinical-stage biotechnology company said it plans to use the net proceeds for working capital and general corporate purposes. It expects to close the deal June 22.Price: 5.43, Change: +1.62, Percent Change: +42.52","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644708013","title":"CervoMed announces $10M registered direct offering priced at-the-market","url":"https://stock-news.laohu8.com/highlight/detail?id=2644708013","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644708013?lang=en_us&edition=fundamental","pubTime":"2026-06-19 00:40","pubTimestamp":1781800810,"startTime":"0","endTime":"0","summary":"CervoMed (CRVO) announced that it has entered into definitive agreements for the purchase and sale of 2,500,000 shares of common stock at a purchas...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cervomed-announces-10m-registered-direct-offering-priced-at-the-market-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cervomed-announces-10m-registered-direct-offering-priced-at-the-market-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644080981","title":"CervoMed prices USD 10 million registered direct stock offering at USD 4 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2644080981","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644080981?lang=en_us&edition=fundamental","pubTime":"2026-06-19 00:35","pubTimestamp":1781800527,"startTime":"0","endTime":"0","summary":"CervoMed priced a registered direct offering of 2,500,000 common shares at USD 4 per share, targeting USD 10 million gross proceeds.Closing expected on or about June 22, 2026, subject to customary closing conditions.Net proceeds earmarked for working capital, general corporate purposes.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDLbcJMN4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BN0W2W23.USD","BK4588","SG9999014013.SGD","BK4112","SG9999014021.USD","LU2210150020.SGD","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU0314104364.USD","CRVO","SG9999014039.USD","NDAQ","LU2095319765.USD","BK4585","IE00BN0W2T93.GBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644080988","title":"CervoMed Announces $10 Million Registered Direct Offering of Common Stock Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2644080988","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644080988?lang=en_us&edition=fundamental","pubTime":"2026-06-19 00:35","pubTimestamp":1781800511,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nTUA26XJTQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644038938","title":"CervoMed Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2644038938","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644038938?lang=en_us&edition=fundamental","pubTime":"2026-06-19 00:35","pubTimestamp":1781800500,"startTime":"0","endTime":"0","summary":"BOSTON, June  18, 2026  (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/18/3314430/0/en/CervoMed-Announces-10-Million-Registered-Direct-Offering-of-Common-Stock-Priced-At-The-Market-Under-Nasdaq-Rules.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345774631.USD","LU0240878834.USD","LU0240877869.USD","LU0348723411.USD","DLB","CRVO","BK4139","LU0205194284.USD","BK4097","LU0205193047.USD","LU0345774391.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644081628","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:11 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2644081628","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644081628?lang=en_us&edition=fundamental","pubTime":"2026-06-18 22:11","pubTimestamp":1781791876,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:11 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nAQN2M46TV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644083303","title":"CervoMed Gains New Patent for Neflamapimod Dementia Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2644083303","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644083303?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:00","pubTimestamp":1781784032,"startTime":"0","endTime":"0","summary":"CervoMed ( ($CRVO) ) just unveiled an update. On June 16, 2026, CervoMed Inc. received a notice of allowance from the U.S. Patent and Trademark Off...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cervomed-gains-new-patent-for-neflamapimod-dementia-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cervomed-gains-new-patent-for-neflamapimod-dementia-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644088933","title":"CervoMed Receives Notice of Allowance for Neflamapimod Patent in Dementia With Lewy Bodies","url":"https://stock-news.laohu8.com/highlight/detail?id=2644088933","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644088933?lang=en_us&edition=fundamental","pubTime":"2026-06-18 19:36","pubTimestamp":1781782573,"startTime":"0","endTime":"0","summary":"CervoMed  received a notice of allowance from the US Patent and Trademark Office related to a patent application for the use of its drug candidate, neflamapimod, for the treatment of dementia with Lewy bodies, the company said Thursday.The patent is expected to cover the treatment of dementia with Lewy bodies without substantial Alzheimer's disease-like tau pathology and is expected to provide intellectual property protection into 2042, with the potential for additional patent term extension, CervoMed said.CervoMed said there are currently no approved treatments for dementia with Lewy bodies in the United States or the European Union.Shares of CervoMed were up more than 5% in Thursday pre-bell activity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644970054","title":"CervoMed - Patent Expected to Provide Ip Protection Into 2042","url":"https://stock-news.laohu8.com/highlight/detail?id=2644970054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644970054?lang=en_us&edition=fundamental","pubTime":"2026-06-18 19:02","pubTimestamp":1781780575,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nFWN42Q0PA:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644700348","title":"CervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia With Lewy Body Patients Into 2042","url":"https://stock-news.laohu8.com/highlight/detail?id=2644700348","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644700348?lang=en_us&edition=fundamental","pubTime":"2026-06-18 19:02","pubTimestamp":1781780575,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nFWN42Q0PA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644355700","title":"CervoMed wins U.S. patent allowance for neflamapimod use in pure Lewy body dementia into 2042","url":"https://stock-news.laohu8.com/highlight/detail?id=2644355700","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644355700?lang=en_us&edition=fundamental","pubTime":"2026-06-18 19:01","pubTimestamp":1781780503,"startTime":"0","endTime":"0","summary":"CervoMed received a USPTO notice of allowance for a US patent covering neflamapimod use in “pure” dementia with Lewy bodies patients.The patent targets DLB patients without substantial Alzheimer’s-like tau pathology, defined by plasma pTau levels or brain imaging.Intellectual property protection is expected to run into 2042, with potential extension through patent term extension.Neflamapimod has completed a Phase 2b RewinD-LB trial; Phase 3 timing depends on partnership or additional financing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL5dCSr6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014021.USD","IE00B64PRP62.GBP","BK4588","SG9999014013.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4585","CRVO","SG9999014039.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","NDAQ","LU0314104364.USD","IE00BN0W2W23.USD","BK4139","IE00BKPKM429.USD","LU2210149790.SGD","LU2210150020.SGD","SG9999014005.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644376485","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2644376485","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644376485?lang=en_us&edition=fundamental","pubTime":"2026-06-17 01:53","pubTimestamp":1781632404,"startTime":"0","endTime":"0","summary":"Space Exploration Technologies  has agreed to acquire Anysphere, which operates artificial intelligence coding agent Cursor, in a deal valued at about $60 billion.Shares jumped 10% intraday, boosting its market value above that of Amazon . More than 240 million shares traded intraday, compared with a daily average of about 384.9 million.CervoMed  shares soared 115% after the company reported to the Securities and Exchange Commission an insider stock purchase worth $3 million late Monday.Over 174.2 million shares traded intraday versus a daily average of roughly 118,000.Netflix  is one of several media companies interested in acquiring Lionsgate Studios , Semafor reported Tuesday, citing a person familiar with the matter.Shares of Lionsgate rose 10% as intraday trading volume grew to over 10.4 million from a daily average of about 3.3 million.Price: 211.93, Change: +19.43, Percent Change: +10.09","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0210533765.USD","LU2896262040.SGD","SPAX","IE00BKPKM429.USD","LU0882574139.USD","LU1778281490.HKD","LU2362540622.SGD","LU0082616367.USD","LU1267930730.SGD","LU2357305700.SGD","BK4585","LU0353189763.USD","IE00B1XK9C88.USD","LU0127658192.USD","SGXZ51526630.SGD","LU2237957811.SGD","BK4507","IE00BKDWB100.SGD","LU2362541513.USD","LU0417517546.SGD","LU2461242641.AUD","LU0868494708.USD","BK4534","LU1046421795.USD","SPCH","IE00BZ1G4Q59.USD","LU0719512351.SGD","LU2860962120.EUR","LU1435385759.SGD","BK4548","SPAL","LU0077335932.USD","BK4532","IE00BQXX3F31.USD","LOFF","LU1069344957.HKD","LU1064131342.USD","LU1823568750.SGD","SPCU","LU1988902786.USD","LU2108987350.USD","LU2552382058.USD","LU0210536198.USD","SPCF","LU1720051017.SGD","LU2543165471.USD","LU0256863811.USD","LU1674673691.USD","LU1674673428.USD","LU0109391861.USD","SSPC","NFXL","BK4598","LU0234572021.USD","LU2552382215.SGD","SGXZ23171101.USD","LU1316542783.SGD","IE00BQXX3C00.GBP","SG9999004303.SGD","LU0198837287.USD","IE00BKVL7J92.USD","LU0203202063.USD","BK4551","LU2361045086.USD","LU0868494617.USD","LU0256863902.USD","LU1429558221.USD","NFLX","LU1814569148.SGD","LU0642271901.SGD","LU0106261372.USD","LU0097036916.USD","BK4527","SGXZ99366536.SGD","LU0672654240.SGD","SGXZ81514606.USD","BK4139","SNK","NFLW","LION","BK4587","IE00BQXX3D17.EUR","BK4566","SPCX","LU1366192091.USD","LU1127390331.HKD","IE00B19Z8X17.USD","LU0942090050.USD","LU0786609619.USD","LU0234570918.USD","LU1989764664.SGD","LU1232071149.USD","NFLU","LU2362541273.HKD","BK4581","LU0203201768.USD","NFXS","LU0215105999.USD","BK4089","LU2264538146.SGD","IE00B19Z8W00.USD","SPCM","LU1720051108.HKD","BK4524","LU0708995401.HKD","LU2237957902.USD","NFLP","LU0353189680.USD","NFLY","LU2087625088.SGD","IE00BWXC8680.SGD","BK4588","SPCQ","LU2552382132.HKD","LU1548497426.USD","BK4108","LU0079474960.USD","LU0225283273.USD","LU2361044865.SGD","IE00B19Z9505.USD","SPCG","CRVO","LU0320765059.SGD","LU1035775433.USD","LU2361044949.HKD","LU0006306889.USD","LU2326559502.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643737687","title":"CervoMed Jumps 29% Pre-Bell After Reporting to SEC Insider Purchase Worth $3 Million Late Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2643737687","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643737687?lang=en_us&edition=fundamental","pubTime":"2026-06-16 16:31","pubTimestamp":1781598660,"startTime":"0","endTime":"0","summary":"CervoMed Jumps 29% Pre-Bell After Reporting to SEC Insider Purchase Worth $3 Million Late Monday","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cervomed.com","stockEarnings":[{"period":"1week","weight":0.0597},{"period":"1month","weight":0.1833},{"period":"3month","weight":-0.1425},{"period":"6month","weight":-0.5443},{"period":"1year","weight":-0.3615},{"period":"ytd","weight":-0.5506}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0195},{"period":"3month","weight":0.1356},{"period":"6month","weight":0.0902},{"period":"1year","weight":0.2004},{"period":"ytd","weight":0.0922}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"CervoMed Inc., a biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. Its lead drug candidate is neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, frontotemporal dementia, and ischemic stroke recovery. The company also develops EIP200 for central nervous system which is in preclinical trials. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.023389},{"month":2,"riseRate":0.5,"avgChangeRate":0.085839},{"month":3,"riseRate":0.5,"avgChangeRate":0.326048},{"month":4,"riseRate":0.3,"avgChangeRate":-0.063988},{"month":5,"riseRate":0.4,"avgChangeRate":0.116259},{"month":6,"riseRate":0.1,"avgChangeRate":-0.109707},{"month":7,"riseRate":0.3,"avgChangeRate":-0.055639},{"month":8,"riseRate":0.666667,"avgChangeRate":0.076308},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.117703},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.039339},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.045938},{"month":12,"riseRate":0.3,"avgChangeRate":-0.206034}],"exchange":"NASDAQ","name":"CervoMed","nameEN":"CervoMed"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.0","shortVersion":"4.45.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CervoMed(CRVO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CervoMed(CRVO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CervoMed,CRVO,CervoMed股票,CervoMed股票老虎,CervoMed股票老虎国际,CervoMed行情,CervoMed股票行情,CervoMed股价,CervoMed股市,CervoMed股票价格,CervoMed股票交易,CervoMed股票购买,CervoMed股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CervoMed(CRVO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CervoMed(CRVO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}